Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Afeyan Noubar
Relationship:   Director, 10% Owner
City:   Lexington
State:   MA
   
Insider Summary:
  
   
Companies Owned :   20    
Direct Shares   7,797,941    

Indirect Shares

  116,914,718      
Direct Value   $20,668,772    

Indirect Value

  $84,459,470      
Total Shares   124,712,659      
Total Value   $105,128,243      


Color Kinetics Inc
 $0 Receptos, Inc.
 $0 Editas Medicine, Inc.
 $20,653,774 Seres Therapeutics, Inc.
 $14,999 Moderna, Inc.
 $0 Color Kinetics Inc
 $0 Receptos, Inc.
 $0 Editas Medicine, Inc.
 $20,653,774 Seres Therapeutics, Inc.
 $14,999 Moderna, Inc.
 $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    10   
    0    

     Stock price went up :

    3   
    0    
     Stock price went down :
    7   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
   -22.5%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Color Kinetics Inc CLRK Director 2005-10-03 83,062 2005-10-03 12,000    Premium*  
            Antigenics Inc AGEN Director 2006-12-14 0 2006-12-14 0    Premium*  
            Helicos Biosciences Corp HLCSQ Director, 10% Owner 2009-09-18 0 2009-09-18 12,192,640    Premium*  
            Receptos, Inc. RCPT 10% Owner 2013-11-18 1,693,551 0    Premium*  
            DNIB Upwind Inc BIND Director, 10% Owner 2013-09-25 0 2013-09-25 1,562,616    Premium*  
            Bg Medicine, Inc. BGMD Director, 10% Owner 2015-12-09 0 2015-12-09 1,286,274    Premium*  
            Editas Medicine, Inc. EDIT 10% Owner 2016-02-08 3,964,256 2016-02-08 991,060    Premium*  
            Selecta Biosciences Inc SELB 10% Owner 2016-06-27 0 2016-06-27 1,651,862    Premium*  
            Kaleido Biosciences, Inc. KLDO 10% Owner 0 2021-02-08 14,907,627    Premium*  
            Transmedics Group, Inc. TMDX 10% Owner 0 2019-10-29 120,595    Premium*  
            Seres Therapeutics, Inc. MCRB 10% Owner 2019-06-18 15,141 2022-07-05 17,617,352    Premium*  
            Moderna, Inc. MRNA 2024-04-24 2,041,931 2024-04-24 9,666,038    Premium*  
            Axcella Health Inc. AXLA 10% Owner 2020-05-18 0 2022-10-13 8,850,296    Premium*  
            Evelo Biosciences Inc EVLO 2020-06-29 0 2023-07-11 4,977,588    Premium*  
            Codiak Biosciences, Inc. CDAK 10% Owner 0 2022-09-15 1,674,869    Premium*  
            Foghorn Therapeutics Inc. FHTX 10% Owner 2020-10-27 0 2020-10-27 1,851,801    Premium*  
            Sigilon Therapeutics, Inc. SGTX 10% Owner 2020-12-08 0 2023-08-11 0    Premium*  
            Sana Biotechnology, Inc. SANA 10% Owner 2021-02-08 0 2023-09-13 581,695    Premium*  
            Rubius Therapeutics, Inc. RUBY Director, 10% Owner 2021-03-19 0 2021-03-19 17,253,519    Premium*  
            Omega Therapeutics, Inc. OMGA Director, 10% Owner 2021-08-03 0 2023-02-27 21,716,886    Premium*  
* Premium Members only  

Records found :    25         Free Registration Required For Full Results.    Limit: 25

Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
MRNA Moderna, Inc.   –       •      –    2024-04-24 4 AS $107.16 $1,624,836 D/D (15,000) 2,041,931 0 -
MRNA Moderna, Inc.   –       •      –    2024-04-17 4 AS $103.10 $1,550,703 D/D (15,000) 2,056,931 0 -
MRNA Moderna, Inc.   –       •      –    2024-04-10 4 AS $106.59 $1,606,865 D/D (15,000) 2,071,931 0 -
MRNA Moderna, Inc.   –       •      –    2024-04-03 4 AS $97.47 $1,525,268 D/D (15,000) 2,086,931 0 -
MRNA Moderna, Inc.   –       •      –    2024-03-27 4 AS $105.73 $1,635,864 D/D (15,000) 2,101,931 0 -
MRNA Moderna, Inc.   –       •      –    2024-03-20 4 AS $101.05 $1,535,820 D/D (15,000) 2,116,931 0 -
MRNA Moderna, Inc.   –       •      –    2024-03-13 4 AS $106.60 $1,628,031 D/D (15,000) 2,131,931 0 -
MRNA Moderna, Inc.   –       •      –    2023-10-25 4 AS $76.73 $769,854 D/D (10,000) 2,156,931 0 -
MRNA Moderna, Inc.   –       •      –    2023-10-11 4 AS $102.88 $1,549,441 D/D (15,000) 2,166,931 0 -
MRNA Moderna, Inc.   –       •      –    2023-10-04 4 AS $100.02 $1,540,845 D/D (15,000) 2,181,931 0 -
MRNA Moderna, Inc.   –       •      –    2023-09-27 4 AS $98.46 $989,646 D/D (10,000) 2,196,931 0 -
MRNA Moderna, Inc.   –       •      –    2023-09-20 4 AS $103.87 $1,571,090 D/D (15,000) 2,206,931 0 -
MRNA Moderna, Inc. Director   –       •      –    2023-09-13 4 AS $108.21 $1,645,522 D/D (15,000) 2,221,931 0 -
SANA Sana Biotechnology, Inc. 10% Owner   –       –       •   2023-09-13 4 D $0.00 $0 I/I (11,781,275) 0 0 -
MRNA Moderna, Inc.   –       •      –    2023-09-06 4 AS $107.27 $1,614,094 D/D (15,000) 1,982,209 0 -
MRNA Moderna, Inc.   –       •      –    2023-08-23 4 AS $112.61 $1,732,613 D/D (15,000) 2,012,209 0 -
MRNA Moderna, Inc.   –       •      –    2023-08-16 4 AS $95.70 $975,614 D/D (10,000) 2,027,209 0 -
SGTX Sigilon Therapeutics, Inc... 10% Owner   –       –       •   2023-08-11 4 D $14.92 $11,901,982 I/I (797,720) 0 0 -
MRNA Moderna, Inc.   –       •      –    2023-08-02 4 AS $110.59 $1,664,876 D/D (15,000) 2,037,209 0 -
MRNA Moderna, Inc.   –       •      –    2023-07-26 4 AS $119.61 $1,806,229 D/D (15,000) 2,052,209 0 -
MRNA Moderna, Inc.   –       •      –    2023-07-19 4 AS $124.14 $1,882,152 D/D (15,000) 2,067,209 0 -
MRNA Moderna, Inc.   –       •      –    2023-07-12 4 AS $124.59 $1,887,081 D/D (15,000) 2,082,209 0 -
EVLO Evelo Biosciences Inc   –       –       •   2023-07-11 4 B $2.31 $12,499,999 I/I 5,411,255 3,931,685 0.01 %
MRNA Moderna, Inc. Director   –       •      –    2023-07-05 4 AS $123.46 $1,870,933 D/D (15,000) 2,097,209 0 -
MRNA Moderna, Inc.   –       •      –    2023-06-28 4 AS $119.84 $1,823,160 D/D (15,000) 2,112,209 0 -

  25  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed